UPDATE: Jefferies Upgrades Pfizer from Hold to Buy, Boosts Target to $38
February 04, 2014 at 12:17 PM EST
Pfizer (NYSE: PFE ) has received an upgraded rating from Hold to Buy and a raised price target from $33 to $38 at Jefferies Tuesday morning. Pfizer's upgrades follows acknowledgments that Oncology and restructuring are key themes for the Pharma sector and Pfizer has both of those covered with palbociclib looking